NCT00049062View on ClinicalTrials.gov

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

anastrozole

DRUG

gefitinib

Trial Locations (1)

78229

Cancer Therapy and Research Center, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00049062 - Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter